ReviewDiscover oncology2024
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer.
Qi Shen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewDiscover oncology2024
Qi Shen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.